Vyloo

Insulin Aspart 100iu medicines online

About Insulin Aspart 100iu

Insulin Aspart 100iu appears as an active ingredient (salt) in various prescription and OTC medicines. Use this page to browse related products listed on Vyloo and match strength and form to your prescription or prior purchase. Product information is educational for shopping only — it is not medical advice. Upload a valid prescription when the product is marked Rx.

View all results
InsuQuick Cartridge16% offRx

InsuQuick Cartridge

USV Ltd · 3.0 ml in 1 box

₹647₹770
InsuQuick Cartridge (3ml each)16% offRx

InsuQuick Cartridge (3ml each)

USV Ltd · 5.0 cartriges in 1 box

₹3,234₹3,850
InsuQuick VDPen16% offRx

InsuQuick VDPen

USV Ltd · 1.0 Solution for Injection in 1 pre-filled pen

₹845₹1,007
InsuQuick Injection16% offRx

InsuQuick Injection

USV Ltd · 10.0 ml in 1 vial

₹2,145₹2,553
Novorapid 100IU Injection16% offRx

Novorapid 100IU Injection

Novo Nordisk India Pvt Ltd · 10.0 ml in 1 vial

₹2,145₹2,553
Novomix 50 Suspension for Injection 100IU/ml16% offRx

Novomix 50 Suspension for Injection 100IU/ml

Novo Nordisk India Pvt Ltd · 3.0 ml in 1 flexpen

₹1,006₹1,198
Fiasp 100IU/ml Solution for Injection16% offRx

Fiasp 100IU/ml Solution for Injection

Novo Nordisk India Pvt Ltd · 10.0 ml in 1 vial

₹1,868₹2,223
Fiasp 100IU/ml Penfill (3ml Each)16% offRx

Fiasp 100IU/ml Penfill (3ml Each)

Novo Nordisk India Pvt Ltd · 3.0 ml in 1 cartridge

₹684₹815
Ryzodeg 100IU/ml Penfill16% offRx

Ryzodeg 100IU/ml Penfill

Novo Nordisk India Pvt Ltd · 3.0 ml in 1 penfill

₹1,040₹1,239
Ryzodeg 100IU/ml Flextouch16% offRx

Ryzodeg 100IU/ml Flextouch

Novo Nordisk India Pvt Ltd · 3.0 ml in 1 pre-filled pen

₹1,040₹1,239
Novomix 50 100IU/ml Penfill16% offRx

Novomix 50 100IU/ml Penfill

Novo Nordisk India Pvt Ltd · 3.0 ml in 1 penfill

₹816₹972
Novomix 30 100IU Penfill (3ml Each)16% offRx

Novomix 30 100IU Penfill (3ml Each)

Novo Nordisk India Pvt Ltd · 1.0 Suspension for Injection in 1 penfill

₹787₹937

Frequently asked questions

All salts · Health conditions · Editorial policy